Abbott Laboratories CDR (ABT)
TSX
Closed
Oct 7, 2026
Day's Range
17.0952 wk Range
14.46Overview - ABT - Abbott Laboratories CDR
Key Statistics
Valuation
Enterprise Value
245.48B
P/E (Trailing)
‪32.25‬
PEG Ratio
‪-0.66‬
Price / Sales (TTM)
‪5.41‬
Price / Book
‪4.49‬
EV / EBITDA
‪20.41‬
Profitability
Profit Margin
‪56.41%‬
Operating Margin
‪20.21%‬
Return on Assets
‪7.52%‬
Return on Equity
‪12.36%‬
Ownership
Shares Outstanding
13.36B
Price stats
50-Day Avg
‪18.60‬
200-Day Avg
‪18.18‬
Dividends
Frequency
Quarterly
Market Cap - ABT - Abbott Laboratories CDR
Peers - ABT - Abbott Laboratories CDR
Peer Comparison
Compared with companies in Medical Devices listed on TSX.
- ABTTSXAbbott Laboratories CDR240.14BMarket Cap-27.43%52-week change32.25P/E (Trailing)‪56.41%‬Profit Margin
- SYKTSXStryker Corporation Depositary Receipt7.03BMarket Cap-9.57%52-week change1.35P/E (Trailing)‪63.96%‬Profit Margin
- OMTSXOsisko Metals Incorporated1.51BMarket Cap+70.17%52-week change-21.25P/E (Trailing)‪0.00%‬Profit Margin
- ECORTSXEcora Royalties PLC756.51MMarket Cap+41.91%52-week change10.45P/E (Trailing)‪69.39%‬Profit Margin
- BSXTSXBelo Sun Mining Corp681.88MMarket Cap+75.41%52-week change-60.00P/E (Trailing)‪0.00%‬Profit Margin
- GBTTSXBMTC Group Inc.413.25MMarket Cap+0.77%52-week change10.65P/E (Trailing)‪6.31%‬Profit Margin
- PRPRNTSXProfound Medical Corp.298.47MMarket Cap+13.22%52-week change-5.79P/E (Trailing)‪-171.56%‬Profit Margin
Profile Summary - ABT - Abbott Laboratories CDR
About
Abbott Laboratories CDR is a Canadian Depositary Receipt providing investors with exposure to Abbott Laboratories, a global leader in healthcare product discovery, development, manufacturing, and sales. The company operates across four key segments: Established Pharmaceutical Products, offering branded generics for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
